封面
市場調查報告書
商品編碼
2077217

歐洲和中東(EME)血氣和電解質分析儀市場:按產品、模式、最終用戶和地區分類

EME Blood Gas and Electrolyte Analyzers Market, By Product, By Modality, By End User, and By Region

出版日期: | 出版商: Coherent Market Insights | 英文 250+ Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

預計到 2026 年,歐洲和中東血氣及電解質分析儀市場規模將達到 1.872 億美元,到 2033 年將達到 2.722 億美元。預計 2026 年至 2033 年的複合年成長率將達到 5.5%。

分析範圍 分析詳情
基準年 2025 市場規模(2026 年) 1.872億美元
效能數據 2020-2024 預測期 2026-2033
預測期(2026-2033 年)複合年成長率 5.50% 預計金額(2033 年) 2.722億美元

血氣分析用於呼吸系統或代謝性疾病的重症患者。除了測量血液中的氧氣、二氧化碳和pH值外,血氣分析還包括測量其他參數的濃度,例如肌酸酐、電解質、葡萄糖、血紅蛋白和乳酸。血氣分析儀使用電極測量血液中的pH值、二氧化碳分壓和氧氣水平。血液中氧氣、二氧化碳和pH值的失衡可能表示某些疾病,例如心臟衰竭、出血、腎衰竭、化學中毒、血糖控制不佳或藥物過量。血氣和電解質分析儀包含血液氣體參數(pH值、二氧化碳分壓、氧分壓)和電解質參數(鈉離子、鉀離子、氯離子、鈣離子)。這些參數用於檢測二氧化碳分壓(PCO2)和氧分壓(PO2)的值。血液氣體和電解質分析儀被認為是診斷呼吸系統或代謝異常患者最重要的工具。血液保護是所有臨床診斷檢查室和重症監護室的關鍵工作。因此,高精度血氣分析儀能夠簡化操作流程,減少誤差,且維護量極低。大多數血氣分析儀都配備直覺的使用者介面和自動化品管(QC) 功能,以確保準確性和符合法規要求,並可實現自動檢體混合和便捷的抽吸。預計在預測期內,慢性病的高發生率和不斷成長的老齡人口將推動歐洲和中東血氣及電解質分析儀市場的成長。

市場動態

預計在預測期內,人口老化加劇以及包括癌症和心血管疾病在內的慢性病盛行率上升,將推動歐洲和中東血氣及電解質分析儀市場成長。例如,根據世界衛生組織(世衛組織)2022年9月的報告,非傳染性疾病死亡病例中,心血管疾病佔絕大多數,每年造成1790萬人死亡,其次是癌症(930萬人)、慢性呼吸系統疾病(410萬人)和糖尿病(200萬人,其中包括糖尿病引起的腎病死亡)。

本報告的主要特點

  • 本報告揭示了各個細分市場的潛在商機,並描述了該市場中一系列有吸引力的投資提案。
  • 此外,它還提供了有關市場促進因素和限制因素、機會、新產品發布和批准、市場趨勢、區域展望以及主要公司採取的競爭策略的重要見解。
  • 本頁面根據公司概況、產品系列、主要趨勢、財務績效和策略等各種參數,對全球歐洲和中東 (EME) 血氣和電解質分析儀市場的主要公司進行了介紹。
  • 本報告中的見解將使負責人和企業經營團隊能夠就未來的產品發布、技術更新、市場擴張和行銷策略做出明智的決策。
  • 《歐洲和中東(EME)血氣和電解質分析儀市場》報告面向該行業的眾多相關人員,包括投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師。
  • 相關人員可以透過各種策略矩陣來促進決策,這些矩陣用於分析歐洲和中東 (EME) 的血氣和電解質分析儀市場。

目錄

第1章:分析目標與假設

  • 分析目的
  • 先決條件
  • 簡稱

第2章 市場展望

  • 報告說明
    • 市場定義和範圍
  • 執行摘要
  • Coherent Opportunity Map(COM)

第3章:市場動態、監管與趨勢分析

  • 市場動態
    • 促進因素
    • 抑制因子
    • 市場吸引力分析
    • 市場機遇
    • 企業合併、商業合作
    • 資金籌措及投資
    • 前景
    • 監管準則與合規性
    • 主要進展
    • PEST分析
    • 波特五力分析

第4章:歐洲和中東(EME)血氣和電解質分析儀市場:按產品類型分類(2021-2033 年)

  • 血氣分析儀
  • 電解質分析儀
  • 複合分析儀
  • 消耗品

第5章:歐洲和中東(EME)血氣和電解質分析儀市場:按模式分類(2021-2033 年)

  • 檢查室分析設備
  • 桌面分析儀
  • 可攜式分析儀

第6章:歐洲和中東(EME)血氣和電解質分析儀市場:按最終用戶分類(2021-2033 年)

  • 醫院
  • 診斷中心
  • 門診手術中心
  • 診所

第7章:歐洲和中東(EME)血氣和電解質分析儀市場:按地區分類(2021-2033 年)

  • 歐洲
    • 英國
    • 德國
    • 義大利
    • 法國
    • 西班牙
    • 北歐的
    • 丹麥
    • 芬蘭
    • 冰島
    • 挪威
    • 瑞典
    • 俄羅斯
    • 其他歐洲國家
  • 中東
    • 沙烏地阿拉伯
    • UAE
    • 土耳其
    • GCC
    • 以色列
    • 其他中東國家

第8章 競爭情勢

  • Abbott
  • Medica Corporation
  • Nova Biomedical
  • Radiometer Medical ApS
  • F.Hoffmann-La Roche Ltd
  • Siemens Healthcare GmbH
  • EKF Diagnostics
  • ERBA Diagnostics Mannheim GmbH
  • Inspira-Technologies OXY BHN LTD
  • Werfen

第9章

  • 分析方法
  • 關於 Coherent Market Insights
簡介目錄
Product Code: CMI3971

Eme Blood Gas And Electrolyte Analyzers Market is estimated to be valued at USD 187.2 Mn in 2026 and is expected to reach USD 272.2 Mn by 2033, growing at a compound annual growth rate (CAGR) of 5.5% from 2026 to 2033.

Report Coverage Report Details
Base Year: 2025 Market Size in 2026: USD 187.2 Mn
Historical Data for: 2020 To 2024 Forecast Period: 2026 To 2033
Forecast Period 2026 to 2033 CAGR: 5.50% 2033 Value Projection: USD 272.2 Mn

Blood gas analysis is performed for critically ill patients suffering from respiratory or metabolic disorders. Blood gas analysis includes measurement of the amount of oxygen, carbon dioxide, and the acidity of pH in the blood as well as concentrations of other parameters such as creatinine, electrolytes, glucose, hemoglobin, and lactate. Blood gas analyzers use electrodes to determine pH, partial pressure of carbon dioxide, and amount of oxygen in the blood. Imbalances in oxygen, carbon dioxide, and pH levels in the blood can indicate the presence of certain medical conditions such as heart failure, hemorrhage, kidney failure, chemical poisoning, uncontrolled diabetes, or drug overdose. Blood gas and electrolyte analyzer include blood gas measuring items (PH, PCO2, and PO2). Electrolyte measuring items (Na+, K+, CH, Ca2+). It is used to detect partial pressure of Carbon Dioxide (PCO2), and partial pressure of Oxygen (PO2) value. Blood gas and electrolyte analyzer is considered the most important tool for diagnosis in patients with either respiratory or metabolic abnormalities. Blood conservation is an important initiative in every clinical diagnostic lab or critical care facility. Therefore, a highly accurate blood gas analyzer can streamline work processes and reduce errors with minimum maintenance. Most blood gas analyzers offer automatic sample mixing and easy sample aspiration with an intuitive user interface built-in and automatic QC for accuracy and regulatory compliance. The high prevalence of chronic diseases and the increasing geriatric population is expected to fuel the growth of the EME blood gas and electrolyte analyzers market over the forecast period.

Market Dynamics

Increasing rates of geriatrics and chronic diseases including cancer and cardiovascular diseases (CVD) is expected to propel the growth of the EME blood gas and electrolyte analyzers market over the forecast period. For instance, in September 2022, according to World Health Organization (WHO), cardiovascular diseases account for most Noncommunicable diseases (NCD) deaths, or 17.9 million people annually, followed by cancers (9.3 million), chronic respiratory diseases (4.1 million), and diabetes (2.0 million including kidney disease deaths caused by diabetes).

Key features of the study:

  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the EME blood gas and electrolyte analyzers market based on the following parameters-company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study are Abbott, Medica Corporation, Nova Biomedical, Radiometer Medical ApS, F. Hoffmann-La Roche Ltd, Siemens Healthcare GmbH, EKF Diagnostics, ERBA Diagnostics Mannheim GmbH, Inspira-Technologies OXY B.H.N. LTD., and Werfen.
  • Insights from this report will allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • EME blood gas and electrolyte analyzers market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the EME blood gas and electrolyte analyzers market

Detailed Segmentation:

  • EME Blood Gas and Electrolyte Analyzers Market, By Product Type (Revenue, USD Mn, 2021 - 2033)
  • Blood Gas Analyzers
  • Electrolyte Analyzers
  • Combination Analyzers
  • Consumables
  • EME Blood Gas and Electrolyte Analyzers Market, By Modality:
  • Laboratory Analyzers
  • Benchtop Analyzers
  • Portable Analyzers
  • EME Blood Gas and Electrolyte Analyzers Market, By End User:
  • Hospitals
  • Diagnostic Centers
  • Ambulatory Surgical Centers
  • Clinics
  • EME Blood Gas and Electrolyte Analyzers Market, By Region (Revenue, USD Mn, 2021 - 2033)
  • Europe
    • U.K.
    • Germany
    • Italy
    • France
    • Spain
    • Nordics
    • Denmark
    • Finland
    • Iceland
    • Norway
    • Sweden
    • Russia
    • Rest of Europe
  • Middle East
    • Saudi Arabia
    • UAE
    • Turkey
    • GCC
    • Israel
    • Rest of Middle East
  • Company Profiles
  • Abbott
  • Medica Corporation
  • Nova Biomedical
  • Radiometer Medical ApS
  • Hoffmann-La Roche Ltd
  • Siemens Healthcare GmbH
  • EKF Diagnostics
  • ERBA Diagnostics Mannheim GmbH
  • Inspira-Technologies OXY B.H.N. LTD.
  • Werfen

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snapshot, By Product Type
    • Market Snapshot, By Modality
    • Market Snapshot, By End User
    • Market Snapshot, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Market Attractiveness Analysis
    • Market Opportunities
    • Merger, Acquisition, Collaborations
    • Funding and Investment
    • Future Prospective
    • Regulatory Guideline and Compliances
    • Key Developments
    • PEST Analysis
    • PORTER's Analysis

4. EME Blood Gas and Electrolyte Analyzers Market, By Product Type, 2021 - 2033, (US$ Million)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2022-2033
    • Segment Trends
  • Blood Gas Analyzers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Million)
  • Electrolyte Analyzers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Million)
  • Combination Analyzers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Million)
  • Consumables
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Million)

5. EME Blood Gas and Electrolyte Analyzers Market, By Modality, 2021 - 2033, (US$ Million)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2022-2033
    • Segments Trends
  • Laboratory Analyzers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Million)
  • Benchtop Analyzers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Million)
  • Portable Analyzers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Million)

6. EME Blood Gas and Electrolyte Analyzers Market, By End User, 2021 - 2033, (US$ Million)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2022-2033
    • Segments Trends
  • Hospitals
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Million)
  • Diagnostic Centers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Million)
  • Ambulatory Surgical Centers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Million)
  • Clinics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Million)

7. EME Blood Gas and Electrolyte Analyzers Market, By Region, 2021 - 2033, (US$ Million)

  • Introduction
    • Market Share Analysis, By Region, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, For Region, 2022-2033
    • Regional Trends
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Modality, 2021 - 2033, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Million)
      • U.K.
      • Germany
      • Italy
      • France
      • Spain
      • Nordics
      • Denmark
      • Finland
      • Iceland
      • Norway
      • Sweden
      • Russia
      • Rest of Europe
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Modality, 2021 - 2033, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Million)
      • Saudi Arabia
      • UAE
      • Turkey
      • GCC
      • Israel
      • Rest of Middle East

8. Competitive Landscape

  • Abbott
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Medica Corporation
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Nova Biomedical
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Radiometer Medical ApS
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • F.Hoffmann-La Roche Ltd
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Siemens Healthcare GmbH
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • EKF Diagnostics
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • ERBA Diagnostics Mannheim GmbH
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Inspira-Technologies OXY B.H.N. LTD
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Werfen
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies

9. Section

  • Research Methodology
  • About Us